Sponsored Content
New Evaluation Standards Needed to Sustain Diabetes Technology Innovation
Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.”
T1D Prevalence Increased Among US Adults Aged 45 to 64
Type 1 diabetes (T1D), which once predominantly affected children, is increasingly affecting older adults in the US, with prevalence rates peaking in those aged 45 to 64, according to recent research.
Reviewing Efficacy, Safety of Weight Loss Therapies in T1D
Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.
Insulin App Recall Prompts FDA Warning After More Than 200 Reported Injuries
Tandem Diabetes Care, Inc has reported 224 injuries associated with a software malfunction in a companion insulin app, leading the company to issue a recall of the technology.
CGM Use Linked to Improved Diabetic Retinopathy Outcomes in T1D
The current study highlights the potential benefit of incorporating continuous glucose monitor (CGM) data into eye care assessments for patients with type 1 diabetes (T1D).
CGM Education Needed to Promote Equitable Diabetes Care
Continuous glucose monitors (CGMs) empower patients with diabetes to take a more active role in managing their condition, but without proper training, many of these advantages become limited.